These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20924284

  • 21. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.
    Njoku C, Self SE, Ruiz P, Hofbauer AF, Gilkeson GS, Oates JC.
    J Investig Med; 2008 Oct; 56(7):911-9. PubMed ID: 18797415
    [Abstract] [Full Text] [Related]

  • 22. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice.
    Shi Y, Yao W, Sun L, Li G, Liu H, Ding P, Hu W, Xu H.
    BMC Nephrol; 2019 Nov 21; 20(1):424. PubMed ID: 31752725
    [Abstract] [Full Text] [Related]

  • 23. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
    Iwata Y, Boström EA, Menke J, Rabacal WA, Morel L, Wada T, Kelley VR.
    J Immunol; 2012 May 01; 188(9):4568-80. PubMed ID: 22467656
    [Abstract] [Full Text] [Related]

  • 24. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep 01; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 25. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
    You Y, Qin Y, Lin X, Yang F, Li J, Sooranna SR, Pinhu L.
    BMC Nephrol; 2015 Aug 27; 16():148. PubMed ID: 26310926
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice.
    Yu CC, Yang CW, Wu MS, Ko YC, Huang CT, Hong JJ, Huang CC.
    J Lab Clin Med; 2001 Jul 27; 138(1):69-77. PubMed ID: 11433230
    [Abstract] [Full Text] [Related]

  • 27. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q, Yang C, Wang Q, Zeng H, Qin W.
    PLoS One; 2015 Jul 27; 10(7):e0133724. PubMed ID: 26208003
    [Abstract] [Full Text] [Related]

  • 28. Angiopoietin-like 4 (ANGPTL4) Suppression Ameliorates Lupus Nephritis in MRL/lpr Mice by Inactivating NLRP3 Inflammasome and Inhibiting Inflammatory Response.
    Luo D, Li J, Hu M, Wang Y, Pi P, Ning M, Wu J.
    Iran J Immunol; 2023 Sep 01; 20(3):316-326. PubMed ID: 37543838
    [Abstract] [Full Text] [Related]

  • 29. STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.
    Zhu J, Chen Y, Chen Y, Lv Y, Chen T.
    Ren Fail; 2024 Dec 01; 46(1):2358187. PubMed ID: 38803234
    [Abstract] [Full Text] [Related]

  • 30. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec 01; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 31. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT, Maeshima A, Kayakabe K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.
    Am J Physiol Renal Physiol; 2017 Feb 01; 312(2):F297-F304. PubMed ID: 27881396
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis.
    Qin L, Du Y, Ding H, Haque A, Hicks J, Pedroza C, Mohan C.
    Arthritis Res Ther; 2019 Jan 08; 21(1):12. PubMed ID: 30621761
    [Abstract] [Full Text] [Related]

  • 35. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
    Wu X, Guo J, Ding R, Lv B, Bi L.
    Acta Histochem; 2015 Oct 08; 117(8):732-7. PubMed ID: 26456520
    [Abstract] [Full Text] [Related]

  • 36. The functional and structural changes of the glomerulus throughout the course of murine lupus nephritis.
    Kiberd BA.
    J Am Soc Nephrol; 1992 Oct 08; 3(4):930-9. PubMed ID: 1450369
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
    Menke J, Bork T, Kutska B, Byrne KT, Blanfeld M, Relle M, Kelley VR, Schwarting A.
    Kidney Int; 2011 Feb 08; 79(4):452-63. PubMed ID: 20980973
    [Abstract] [Full Text] [Related]

  • 39. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Tan H, Zhao J, Wang S, Zhang L, Wang H, Huang B, Liang Y, Yu X, Yang N.
    Int Immunopharmacol; 2012 Dec 08; 14(4):401-9. PubMed ID: 22922317
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.